Efficacy and safety of MT10107 (Coretox ®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial

To compare the efficacy and safety of MT10107 (Coretox ®) with those of onabotulinum toxin A (Botox®) in patients with post-stroke upper limb spasticity

Source: Archives of Physical Medicine and Rehabilitation - May 31, 2020 Category: Rehabilitation Authors: Junekyung Lee, Min Ho Chun, Young Jin Ko, Shi-Uk Lee, Deog Young Kim, Nam-Jong Paik, Bum Sun Kwon, Yoon Ghil Park Source Type: research